David Levine to Antihypertensive Agents
This is a "connection" page, showing publications David Levine has written about Antihypertensive Agents.
Connection Strength
0.292
-
Young JH, Ng D, Ibe C, Weeks K, Brotman DJ, Dy SM, Brancati FL, Levine DM, Klag MJ. Access to Care, Treatment Ambivalence, Medication Nonadherence, and Long-Term Mortality Among Severely Hypertensive African Americans: A Prospective Cohort Study. J Clin Hypertens (Greenwich). 2015 Aug; 17(8):614-21.
Score: 0.107
-
Cen? CW, Dennison CR, Powell Hammond W, Levine D, Bone LR, Hill MN. Antihypertensive medication nonadherence in black men: direct and mediating effects of depressive symptoms, psychosocial stressors, and substance use. J Clin Hypertens (Greenwich). 2013 Mar; 15(3):201-9.
Score: 0.091
-
Cooper LA, Roter DL, Carson KA, Bone LR, Larson SM, Miller ER, Barr MS, Levine DM. A randomized trial to improve patient-centered care and hypertension control in underserved primary care patients. J Gen Intern Med. 2011 Nov; 26(11):1297-304.
Score: 0.082
-
Hill MN, Han HR, Dennison CR, Kim MT, Roary MC, Blumenthal RS, Bone LR, Levine DM, Post WS. Hypertension care and control in underserved urban African American men: behavioral and physiologic outcomes at 36 months. Am J Hypertens. 2003 Nov; 16(11 Pt 1):906-13.
Score: 0.012